Pay in 4 interest-free payments of $7.01 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
As clinicians increasingly encounter patients with IBD as well as obesity, diabetes, or metabolic liver disease, there is a clear need to synthesize what is known about safety, metabolic effects, and IBD-specific outcomes to support evidence-informed clinical decision-making, explains senior investigator and study author Jolle St-Pierre, MD, PhD, FRCPC, a clinical assistant professor in the Division of Gastroenterology and Hepatology at the University of Calgary, Canada, in an email to Gastro Today
[DOI] [PubMed] [Google Scholar] 109.Paulson D.J., Schmidt M.J., Traxler J.S., Ramacci M.T., Shug A.L
Chemotherapy-induced damage to ovary: mechanisms and clinical impact
Sekundrer Carnitinmngel : Ein sekundrer Carnitinmngel geht auf bestimmte Erkrankungen z
US$ 21.55
US$ 28.71
US$ 27.27
US$ 24.49
US$ 20.19
US$ 28.34
US$ 21.87
US$ 23.60
